Stocktoria

Embecta Corp. EMBC

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-03-21
Chart by TradingView
6/9
Piotroski F — financial health
1.99
Altman Z″ — distress risk · grey
36.7%
Dividend payout · safe

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$1.1B$1.1B$1.1B$1.1B$1.2B
Gross profit$676.8M$735.2M$749.9M$774.9M$800.4M
Operating income$242.1M$166.8M$221.5M$309.6M$492.0M
Net income$95.4M$78.3M$70.4M$223.6M$414.8M
Operating cash flow$191.7M$35.7M$67.7M$412.2M$456.3M
Free cash flow$182.4M$19.9M$41.2M$388.6M$419.5M
Total assets$1.1B$1.3B$1.2B$1.1B$788.0M
Shareholders' equity-$650.6M-$738.3M-$821.7M-$891.4M$594.3M
Ratios
Gross margin62.6%65.5%66.9%68.6%68.7%
Operating margin22.4%14.9%19.8%27.4%42.2%
Net margin8.8%7.0%6.3%19.8%35.6%
FCF margin16.9%1.8%3.7%34.4%36.0%
Return on assets8.7%6.1%5.8%20.6%52.6%
Return on equity-14.7%-10.6%-8.6%-25.1%69.8%
Debt / equity-2.13×-2.12×-1.94×-1.79×0.00×
Current ratio2.412.032.122.211.78
Revenue growth-3.8%0.2%-0.8%-3.1%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC144,287$1.3M

Why these scores methodology →

Piotroski F-score: 6/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 1.99 (grey)

  • Working capital / assets 0.339
  • Retained earnings / assets -0.408
  • EBIT / assets 0.222
  • Equity / liabilities -0.374

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001872789 · as of 2025-09-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.